Audiologists in Elkhart, IN Accepting Medicare

5 Audiologists found. Showing 1 - 5

Abigail Anne Johnson, M.A. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 303 S Nappanee St, Elkhart, IN 46514 Phone: 574-296-3200    Fax: 574-296-3392

Ms. Karen L. Zigon, MA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 303 S Nappanee St, Elkhart, IN 46514 Phone: 574-296-3291    Fax: 574-296-3383

Jordan Leigh Bergstrom, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1753 Fulton St, Elkhart, IN 46514 Phone: 574-293-9448    Fax: 574-293-9480

Alexa M Rozycki, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1753 Fulton St, Elkhart, IN 46514 Phone: 574-293-9448    Fax: 574-293-9480

Patricia Welty, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1755 Fulton St, Suite A, Elkhart, IN 46514 Phone: 574-296-3200    Fax: 574-296-3392

News Archive

Drug given to stop miscarriages doubles breast cancer risk for daughters

Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.

Octapharma AG submits Biological License Application for its octagam(R) 10% to FDA

Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.

Brain tissue created from human skin cells

British scientists have successfully generated brain tissue from human skin. The team has for the first time generated a crucial type of brain cells in the laboratory by reprogramming skin cells. They say it could speed up the hunt for new treatments for conditions such as Alzheimer's disease, epilepsy and stroke.

Musashi 2 protein predicts progression of AML and CML, identify researchers

Researchers at Whitehead Institute and Children's Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia and chronic myeloid leukemia patients.

Read more Medical News

› Verified 4 days ago